Kyungpook national university hospital Clionical center
Daegu, Gyeongsangbuk-do, 700-721, South Korea
NCT Number: NCT01806363
Clinical trial to evaluate the pharmacokinetic interactions and safety between telmisartan and chlorthalidone.
Looking for future studies?
Notify Me20 year–50 year
Male
Interventional
Phase 1
Daegu, Gyeongsangbuk-do, 700-721, South Korea
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Over a 24-hour sampling period
Time frame: Over a 24-hour sampling period
Time frame: Over a 24-hour sampling period
Time frame: Over a 24-hour sampling period
HanAll BioPharma Co., Ltd.
Industry
A Phase I Clinical Trial to Evaluate the Pharmacokinetic Interactions and Safety Between Telmisartan and Chlorthalidone in Healthy Male Volunteers.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05610059
Aging, Behavior
Tucson, Arizona, United States
View Trial DetailsNCT02439775
Cardiovascular Diseases, Hypertension
Huntsville, Alabama, United States
View Trial DetailsNCT07735468
Behavior, Cardiovascular Diseases
Osuna, Sevilla, Spain
View Trial DetailsNCT00837122
Cardiovascular Diseases, Diabetes
Accra, Ghana
View Trial Details